CAS No.129722-12-9,Aripiprazole Suppliers

Products Categories

Pharmaceutical (258)
Others (76)
Organic Chemicals (35)
Reagent (5)
Plant Extract (5)
Materials (4)
(1)
Synthetic Flavours & Fragrances (1)

Basic Information

Molecular Structure:
CAS No.:	129722-12-9
Name:	Aripiprazole
Article Data:	62

Formula:	C₂₃H₂₇Cl₂N₃O₂
Molecular Weight:	448.392
Synonyms:	Aripiprazole [USAN];Aripiprazole (JAN/USAN);2(1H)-Quinolinone,7-[4-[4-(2,3-dichlorophenyl)- 1-piperazinyl]butoxy]-3,4-dihydro-;7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone;Abilitat;7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone;OPC-14597;Abilify (TN);Abilify;7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one;OPC 31;2(1H)-Quinolinone, 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-;Opc 14597;Arpiprazole;Alipiprazole;Aripiprzole;Aripipazole;7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one;
EINECS:	200-835-2
Density:	1.263 g/cm³
Melting Point:	139 °C
Boiling Point:	646.2 °C at 760 mmHg
Flash Point:	344.6 °C
Appearance:	colourless flake crystalline solid
Hazard Symbols:	F,Xn
Risk Codes:	11-20/21/22-36
Safety:	16-36/37
PSA:	44.81000
LogP:	5.00020

Synthetic route

: 1026778-41-5
Aripiprazole hydrochloride

: 129722-12-9
aripiprazole

Conditions

Conditions	Yield
at 100 - 120℃; for 21h; Industrial scale;	99.3%
With sodium hydroxide; water In isopropyl alcohol at 15 - 80℃; for 4.5h; pH=>= 12;
With sodium hydroxide In methanol; water at 20 - 45℃;

: 1-(2,3-dichlorophenyl)-piperazine hydrochloride

: 120004-79-7
3,4-dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone

: 129722-12-9
aripiprazole

Conditions

Conditions	Yield
With potassium carbonate In water for 3h; Reflux;	98%
With potassium carbonate In water for 3h; Reflux;	98%
With potassium carbonate In water at 90 - 95℃; for 4h;	92.8%

: 884596-21-8
7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone methanol solvate

: 129722-12-9
aripiprazole

Conditions

Conditions	Yield
In isopropyl alcohol Product distribution / selectivity;	96.8%
In acetonitrile for 2h; Product distribution / selectivity; Heating / reflux;	91.4%
In Isopropyl acetate for 2h; Product distribution / selectivity; Heating / reflux;	85.7%

: 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone ethanol hemisolvate

: 129722-12-9
aripiprazole

Conditions

Conditions	Yield
In isopropyl alcohol Product distribution / selectivity;	94.6%
In ethyl acetate Product distribution / selectivity; Heating / reflux;
at 90℃; for 6h; Product distribution / selectivity;
at 80℃; for 15h; Product distribution / selectivity;

: 120004-79-7
3,4-dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone

: 41202-77-1
1-(2,3-dichlorophenyl)piperazine

: 129722-12-9
aripiprazole

Conditions

Conditions	Yield
Stage #1: 7-(4-chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one With sodium iodide In N,N-dimethyl-formamide at 70 - 80℃; for 1h; Stage #2: 1-(2,3-dichlorophenyl)piperazine With potassium carbonate In N,N-dimethyl-formamide at 70 - 80℃; for 4h;	94%
With potassium carbonate In N,N-dimethyl-formamide at 100℃;	57 mg

: 201230-82-2
carbon monoxide

: 1-(2,3-dichlorophenyl)-4-(4-(3-nitro-4-vinylphenoxy)butyl)piperazine

: 129722-12-9
aripiprazole

Conditions

Conditions	Yield
With palladium (II) nitrate; 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl In tetrahydrofuran; water at 50℃; under 30003 Torr; for 20h; Pressure; Temperature; Reagent/catalyst;	94%
With palladium(II) trifluoroacetate; toluene-4-sulfonic acid In tetrahydrofuran at 80℃; under 26601.8 Torr; for 20h; regioselective reaction;	1.074 g

: 851220-85-4
aripiprazole monohydrate

: 129722-12-9
aripiprazole

Conditions

Conditions	Yield
In isopropyl alcohol Product distribution / selectivity;	93.6%
at 60 - 125℃; for 1 - 50h; Conversion of starting material;

: 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydrocarbostyril DL-tartrate

: 129722-12-9
aripiprazole

Conditions

Conditions	Yield
With ammonia; water In chloroform at 30 - 35℃; for 0.333333h; Product distribution / selectivity;	93.43%

: 22246-18-0
7-hydroxy-3,4-dihydro-2-(1H)-quinolinone

: C14H19Cl3N2*ClH

: 129722-12-9
aripiprazole

Conditions

Conditions	Yield
With potassium carbonate In water at 99℃; for 5h; Reagent/catalyst; Temperature;	91.4%

: 1258382-04-5
7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)-butoxy)-3,4-dihydro-2(1H)-carbostyril maleate

: 129722-12-9
aripiprazole

Conditions

Conditions	Yield
With sodium hydroxide In water; toluene at 65℃; for 0.25h; pH=~ 11; Product distribution / selectivity;	91%
With sodium hydroxide In water; toluene at 65 - 80℃; for 0.5h; pH=~ 11;	91%

Raw Materials

104-15-4

Downstream Products

Total:279 Page 1 of 8 1 2 3 4 5 6 …8 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 129722-12-9

Chemistry

Molecular structure of Aripiprazole (CAS NO.129722-12-9) is:

Product Name: Aripiprazole
CAS Registry Number: 129722-12-9
IUPAC Name: 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
Molecular Weight: 448.38538 [g/mol]
Molecular Formula: C₂₃H₂₇Cl₂N₃O₂
XLogP3-AA: 4.6
H-Bond Donor: 1
H-Bond Acceptor: 4
Melting Point: 139 °C
Surface Tension: 48.4 dyne/cm
Density: 1.263 g/cm³
Flash Point: 344.6 °C
Enthalpy of Vaporization: 95.31 kJ/mol
Boiling Point: 646.2 °C at 760 mmHg
Vapour Pressure: 1.38E-16 mmHg at 25°C
Product Categories: Inorganic & Organic chemicals;Active Pharmaceutical Ingredients;API;Heterocyclic Compounds;Chemistry;Intermediates & Fine Chemicals;Neurochemicals;Pharmaceuticals;Isotope Labeled Compounds

History

Aripiprazole (CAS NO.129722-12-9) was approved by the Food and Drug Administration on November 15, 2002 for the treatment of schizophrenia, the sixth atypical antipsychotic medication of its kind. More recently, it received FDA approval for the treatment of acute manic and mixed episodes associated with bipolar disorder, and as an adjunct for the treatment of major depressive disorder.It was developed by Otsuka in Japan; in the U.S., Otsuka America markets the drug jointly with Bristol-Myers Squibb.

Uses

Aripiprazole (CAS NO.129722-12-9) is used for the treatment of schizophrenia, the sixth atypical antipsychotic medication of its kind and for the treatment of acute manic and mixed episodes, in both pediatric patients aged 10–17 and in adults. Also it is used as an adjunct for the treatment of major depressive disorder. It has been approved by the FDA for the treatment of schizophrenia and for the treatment of unipolar depression when used adjunctively with an antidepressant medication.Also, it can treat irritability in persons with autism.

Specification

Aripiprazole , its cas register number is 129722-12-9. It also can be called Aripiprazole [USAN] ; 7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone ; 7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril ; 7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone ; Abilify ; Abilify Discmelt ; Abilitat ; Discmelt ; 2(1H)-Quinolinone, 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro- .It is a colourless flake crystalline solid.